E
Elias Toubi
Researcher at Technion – Israel Institute of Technology
Publications - 164
Citations - 8565
Elias Toubi is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Autoantibody & Autoimmunity. The author has an hindex of 45, co-authored 164 publications receiving 7667 citations. Previous affiliations of Elias Toubi include Bar-Ilan University & San Diego State University.
Papers
More filters
Journal ArticleDOI
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.
Torsten Zuberbier,Werner Aberer,Riccardo Asero,Carsten Bindslev-Jensen,Zenon Brzoza,Giorgio Walter Canonica,Martin K. Church,Luis Felipe Ensina,Ana Giménez-Arnau,Kiran Godse,Margarida Gonçalo,Clive Grattan,Jacques Hébert,Michihiro Hide,Allen P. Kaplan,Alexander Kapp,A H Abdul Latiff,P. Mathelier-Fusade,Martin Metz,Alexander Nast,Sarbjit S. Saini,Mario Sánchez-Borges,Peter Schmid-Grendelmeier,F. E. R. Simons,Petra Staubach,Gordon Sussman,Elias Toubi,Gino A. Vena,Bettina Wedi,X J Zhu,Markus Maurer +30 more
TL;DR: This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms, and outlines evidence-based diagnostic and therapeutic approaches for the different subtypes ofUrticaria.
Journal ArticleDOI
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.
Torsten Zuberbier,Werner Aberer,Riccardo Asero,A H Abdul Latiff,Diane Baker,Barbara Ballmer-Weber,Jonathan A. Bernstein,Carsten Bindslev-Jensen,Zenon Brzoza,R Buense Bedrikow,G.W. Canonica,Martin K. Church,Timothy J. Craig,I V Danilycheva,Corinna Dressler,Luis Felipe Ensina,Ana Giménez-Arnau,Kiran Godse,Margarida Gonçalo,Clive Grattan,Jacques Hébert,Michihiro Hide,Allen P. Kaplan,Alexander Kapp,C. Katelaris,Emek Kocatürk,Kanokvalai Kulthanan,D. Larenas-Linnemann,Tabi A. Leslie,Markus Magerl,P. Mathelier-Fusade,R. Y. Meshkova,Martin Metz,Alexander Nast,Eustachio Nettis,Hanneke Oude-Elberink,Stefanie Rosumeck,Sarbjit S. Saini,Mario Sánchez-Borges,Peter Schmid-Grendelmeier,Petra Staubach,Gordon Sussman,Elias Toubi,Gino A. Vena,Christian Vestergaard,Bettina Wedi,Ricardo Niklas Werner,Zuotao Zhao,Marcus Maurer +48 more
TL;DR: In this paper, an evidence-and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group.
Journal ArticleDOI
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema
Marco Cicardi,Aleena Banerji,F. Bracho,Alejandro Malbrán,Bernd Rosenkranz,Marc A. Riedl,Konrad Bork,William R. Lumry,Werner Aberer,Henning Bier,Murat Bas,Jens Greve,Thomas K. Hoffmann,Henriette Farkas,Avner Reshef,Bruce Ritchie,William H. Yang,Jürgen Grabbe,Shmuel Kivity,Wolfhart Kreuz,Robyn J. Levy,Thomas A. Luger,Krystyna Obtułowicz,Peter Schmid-Grendelmeier,Christian Bull,Brigita Sitkauskiene,William B Smith,Elias Toubi,Sonja Werner,Suresh Anné,Janne Björkander,Laurence Bouillet,Enrico Cillari,D. Hurewitz,Kraig W. Jacobson,Constance H. Katelaris,Marcus Maurer,Hans F. Merk,Jonathan A. Bernstein,Conleth Feighery,Bernard Floccard,Gerald J. Gleich,Jacques Hébert,Martin Kaatz,Paul K. Keith,Charles H. Kirkpatrick,David Langton,Ludovic Martin,Christiane Pichler,David Resnick,Duane Wombolt,Diego S. Fernández Romero,Andrea Zanichelli,Francesco Arcoleo,Jochen Knolle,Irina Kravec,Liying Dong,Jens Zimmermann,Kimberly Rosen,Wing Tze Fan +59 more
TL;DR: In patients with hereditary angioedema having acute attacks, a significant benefit of icatibant as compared with tranexamic acid in one trial and a nonsignificantbenefit of ic atibant in the other trial are found with regard to the primary end point.
Journal ArticleDOI
The EAACI/GA 2 LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
Torsten Zuberbier,Werner Aberer,Riccardo Asero,Carsten Bindslev-Jensen,Zenon Brzoza,Giorgio Walter Canonica,Martin K. Church,Luis Felipe Ensina,Ana Giménez-Arnau,Kiran Godse,Margarida Gonçalo,Clive Grattan,Jacques Hébert,Michihiro Hide,Allen P. Kaplan,Alexander Kapp,A H Abdul Latiff,P. Mathelier-Fusade,Martin Metz,Alexander Nast,Sarbjit S. Saini,Mario Sánchez-Borges,Peter Schmid-Grendelmeier,F. E. R. Simons,Petra Staubach,Gordon Sussman,Elias Toubi,Gino A. Vena,Bettina Wedi,X J Zhu,Markus Maurer +30 more
TL;DR: This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomecha.
Journal ArticleDOI
Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients
TL;DR: This data indicates that continuation of an aggressive treatment with cyclosporine A for chronic urticaria is a viable option and may even be a viable treatment option for some patients with severe CU.